Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-Bromopyridazine hydrobromide → 4-(5-Pyridazin-4-yl-2,3-dihydro-benzofuran-2-yl)-piperidine-1-carboxylic acid tert-butyl ester
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-Bromopyridazine hydrobromide | HCID 53407906 | — |
| 반응물 | 4-[5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-2,3-dihydro-benzofuran-2-yl]-piperidine-1-carboxylic acid tert-butyl ester | HCID 67973629 | — |
| 생성물 | 4-(5-Pyridazin-4-yl-2,3-dihydro-benzofuran-2-yl)-piperidine-1-carboxylic acid tert-butyl ester | HCID 67990213 | — |
반응 단계
The title compound is prepared from 4-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-2,3-dihydro-benzofuran-2-yl]-piperidine-1-carboxylic acid tert-butyl ester and 4-bromopyridazine hydrobromide following a procedure analogous to that described in Example 1. LC (method 6): tR=1.19 min; Mass spectrum (ESI+): m/z=382 [M+H]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08669271B2 |
| 출처 데이터셋 | uspto-grants-2014_03 |
| ORD ID | ord-3b7cadd347784a339a74745d65af36d1 |
| 출처 메모 | uspto-grants-2014_03 |